21st Nov 2006 07:01
Syntopix Group plc21 November 2006 For immediate release 21 November 2006 SYNTOPIX GROUP PLC ("Syntopix" or "the Company") ANNUAL REPORT AND NOTICE OF AGM Syntopix Group plc (AIM: SYN), the drug discovery and development companyfocused on dermatological diseases, announces that, further to the preliminaryresults announcement made on 28 September 2006, the Annual Report and Accounts2006 has now been posted to shareholders. It is also available on the Company'swebsite via the link www.syntopix.com/pdf/SyntopixAnnualReport2006.pdf . The Annual Report includes notice of the Company's Annual General Meeting forshareholders, which will be held at 12pm on 12 December 2006 at the offices ofWalker Morris, 12 King Street, Leeds LS1 2HL. For further information please contact: Syntopix Group plc 0845 125 9204Darren Bamforth, Finance Directorwww.syntopix.com KBC Peel Hunt Ltd 020 7418 8900Megan MacIntyre Buchanan Communications 020 7466 5000Mark Court, Tim Anderson, Mary-Jane Johnson About Syntopix Group plc Syntopix Group plc began as a spin-out company from the University of Leeds.The Syntopix strategy is designed to reduce the risks and costs of drugdevelopment by avoiding the use of new chemical entities. Flotation on AiM inMarch 2006 enabled the Company to take its first candidate products into thedevelopment pipeline. The Company's therapeutic focus is currently on acne andstaphylococcal skin infections. Syntopix has a collaborative approach and willwork with partners in the pharmaceutical and healthcare sector to expedite arapid route to market. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Gunsynd